Extracoporeal shockwave treatment decreases pain, functional limitations and medial collateral ligament thickness in subjects aged 50-70 years with knee osteoarthritis

Main Article Content

Andwi Setiawan Kokok
Tirza Z Tamin
Nyoman Murdana
Indah Suci Widyahening


Pain from knee and hip osteoarthritis (OA) can have a significant impact on the physical function and quality of life of affected individuals worldwide. The objective of this study was to evaluate the effect of extracorporeal shockwave therapy (ESWT) on pain, flexibility, function, and medial collateral ligament (MCL) thickness in knee osteoarthritis (KOA).

A study of quasi experimental design was performed involving 15 subjects aged 50 – 70 years with Kellgren-Lawrence grade 2-3 KOA. All subjects were evaluated regarding baseline -pain using visual analogue scale (VAS), range of motion (ROM), functional outcome using Western Ontario and McMaster Universities Arthritis Index (WOMAC), and MCL size. Extracorporeal shock wave therapy was given 3 times, at baseline, and 4 and 8 weeks after intervention. All subjects were given 4000 shocks at intensities of 1.5 – 4 Bar (raised gradually) per session. The shocks were given in the supine position, knee flexed 90o, without topical anesthetic. Statistical analyses were conducted using a dependent t-test.

After 8 weeks of intervention, ESWT significantly improved pain score (p<0.01), WOMAC (p<0.01) and MCL thickness (p<0.01) in patients with OA of the knee. However, there was no significant difference in knee ROM, both for degree of flexion and extension (p>0.05).

The use of ESWT for treatment of knee OA had a beneficial effect on pain relief, function outcome and MCL thickness. However, there remains a lack of clarity regarding the frequency and dosage levels of ESWT required to achieve maximum improvement.

Article Details

How to Cite
Kokok, A. S., Tamin, T. Z., Murdana, N., & Widyahening, I. S. (2021). Extracoporeal shockwave treatment decreases pain, functional limitations and medial collateral ligament thickness in subjects aged 50-70 years with knee osteoarthritis. Universa Medicina, 40(2), 118–129. https://doi.org/10.18051/UnivMed.2021.v40.121-132
Original Articles


Neogi T. The epidemiology and impact of pain in osteoarthritis. Osteoarthritis Cartilage 2013;21:1145-53. doi: 10.1016/j.joca.2013.03.018.

Wallace IJ, Worthington S, Felson DT, et al. Knee osteoarthritis has doubled in prevalence since the mid-20th century. Proc Natl Acad Sci USA 2017;114:9332–6. doi: 10.1073/pnas.1703856114.

Ahmad IW, Rahmawati LD, Wardhana TH. Demographic profile, clinical and analysis of osteoarthritis patients in Surabaya. Biomol Health Sci J 2018;1:34. doi:10.20473/bhsj.v1i1.8208.

Medical Rehabilitation Department RSCM Outpatient Data 2016. Jakarta: Medical Rehabilitation Department RSCM;2016.

Palazzo C, Nguyen C, Lefevre-Colau MM, Rannou F, Poiraudeau S. Risk factors and burden of osteoarthritis. Ann Physic Rehab Med 2016;59:134-8. doi:10.1016/j.rehab.2016.01.006.

Cho SJ, Yang JR, Yang HS, Yang HE. Effects of extracorporeal shockwave therapy in chronic stroke patients with knee osteoarthritis: a pilot study. Ann Rehabil Med 2016;40:862-70. doi: 10.5535/arm.2016.40.5.862.

Lee JK, Lee BY, Shin WY, An MJ, Jung KI, Yoon SR. Effect of extracorporeal shockwave therapy versus intra-articular injections of hyaluronic acid for the treatment of knee osteoarthritis. Ann Rehabil Med 2017;41:828-35. doi: 10.5535/arm.2017.41.5.828.

Zhao Z, Jing R, Shi Z, Zhao B, Ai Q, Xing G. Efficacy of extracorporeal shockwave therapy for knee osteoarthritis: a randomized controlled trial. J Surg Res 2013;185:661–6. doi: 10.1016/j.jss.2013.07.004.

Lee SJ, Kang JH, Kim JY, Kim JH, Yoon SR, Jung KI. Dose-related effect of extracorporeal shock wave therapy for plantar fasciitis. Ann Rehabil Med 2013;37:379–88. doi: 10.5535/arm.2013.37.3.379.

Zhao Z, Ji H, Jing R, et al. Extracorporeal shock-wave therapy reduces progression of knee osteoarthritis in rabbits by reducing nitric oxide level and chondrocyte apoptosis. Arch Orthop Trauma Surg 2012;132:1547–53. doi: 10.1007/s00402-012-1586-4.

Li W, Pan Y, Yang Q, Guo ZG, Yue Q, Meng Q. Extracorporeal shockwave therapy for the treatment of knee osteoarthritis. Medicine (Baltimore) 2018;97:e11418. doi: 10.1097/MD.0000000000011418.

Imamura M, Alamino S, Hsing WT, Alfieri FM, Schmitz C, Battistela LR. Radial extracorporeal shock wave therapy for disabling pain due to severe primary knee osteoarthritis. J Rehabil Med 2017;49:54-62. doi: 10.2340/16501977-2148.

Lizis P, Kobza W, Manko G. Extracorporeal shockwave therapy vs. kinesiotherapy for osteoarthritis of the knee: A pilot randomized controlled trial. J Back Musculoskelet Rehabil 2017;30:1121-8. doi: 10.3233/BMR-169781.

Andrews K, Lu A, Mckean L, Ebraheim N. Review: Medial collateral ligament injuries. J Orthop 2017;14:550–4. doi: 10.1016/j.jor.2017.07.017.

Delgado DA, Lambert BS, Boutris N, , et. al. Validation of digital visual analog scale pain scoring with a traditional paper-based visual analog scale in adults. J Am Acad Orthop Surg Glob Res Rev 2018;2:e088. doi: 10.5435/JAAOSGlobal-D-17-00088.

Mascarin NC, Vancini RL, Andrade MDS, Magalhaes EDP, Lira CAB, Coimbra IB. Effects of kinesiotherapy, ultrasound and electrotherapy in management of bilateral knee osteoarthritis: prospective clinical trial. BMC Musculoskelet Disord 2012;13:182. doi: 10.1186/1471-2474-13-182.

Madani H, Tincey S, Tavare AN, Drumm O, Chan O. Chronic MCL syndrome: anatomy, pathology, clinical presentation and treatment. Proceeding of the European Society Radiology 2015. London 291:C:2071. doi: 10.1594/ecr2015/C-2071.

Schmitz C, Milz S, Schieker M, Maffulli N, Rompe J-D, Furia JP. Efficacy and safety of extracorporeal shock wave therapy for orthopedic conditions: a systematic review on studies listed in the PEDro database. Br Med Bull 2015;116:115-38. doi: 10.1093/bmb/ldv047.

Concoff A, Rosen J, Fu F, et al. A comparison of treatment effects for nonsurgical therapies and the minimum clinically important difference in knee osteoarthritis. JBJS Rev 2019;7:e5. doi: 10.2106/JBJS.RVW.18.00150.

Xu YM, Wu K, Liu Y, et al. The effect of extracorporeal shock wave therapy on the treatment of moderate to severe knee osteoarthritis and cartilage lesion. Medicine (Baltimore) 2019;98: e15523. doi: 10.1097/MD.0000000000015523.

Sanzo P. The physiological effects of extracorporeal shockwave therapy in the treatment of plantar fasciitis and other musculoskeletal conditions. Orthop Division Rev 2012;25:1-8. doi: 10.1186/1749-799X-7-11.

Mokhtar M, Singh P, editors. Neuroanatomy, periaqueductal gray. Treasure Island (FL): StatPearls Publishing; 2021.

Iyengar S, Ossipov MH, Johnson KW. The role of calcitonin gene–related peptide in peripheral and central pain mechanisms including migraine. Pain 2017;158:543–59. doi: 10.1097/j.pain.0000000000000831.

Wijayanti I, Murdana IN, Tamin TZ, Kekalih AK. Perbandingan efektivitas extracorporeal shockwave therapy dosis menengah dengan extracorporeal shockwave therapy dosis tinggi terhadap tendinitis kalsifikasi rotator cuff (tesis). Jakarta: Program Pendidikan Dokter Spesialis IKFR FKUI; 2017.

Alves TI, Girish G, Brigido MK, Jacobson MJA. US of the knee: scanning techniques, pitfalls, and pathologic conditions. Radio Graphics 2016;36:1759–75. Doi: 10.1148/rg.2016160019.

Liao CG, Xie GM, Tsauo JY, Chen HC, Liou TH. Efficacy of extracorporeal shock wave therapy for knee tendinopathies and other soft tissue disorders: a meta-analysis of randomized controlled trials. BMC Musculoskelet Disord 2018;19:278. doi: 10.1186/s12891-018-2204-6.